Pacific Biosciences
PACB
PACB
143 hedge funds and large institutions have $592M invested in Pacific Biosciences in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 41 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 29
52% less call options, than puts
Call options by funds: $697K | Put options by funds: $1.45M
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
143
Holding in Top 10
–
Calls
$697K
Puts
$1.45M
Top Buyers
| 1 | +$27.1M | |
| 2 | +$19.6M | |
| 3 | +$17.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$15.4M |
| 5 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$4.15M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$26.2M | |
| 3 | -$19M | |
| 4 |
VI
Versor Investments
New York
|
-$11.4M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$9.34M |